title: Potency of a vaccine prepared from A/swine/Hokkaido/2/1981 (H1N1) against A/Narita/1/2009 (H1N1) pandemic influenza virus strain.
abstract: BACKGROUND
  The pandemic 2009 (H1N1) influenza virus has spread throughout the world and is now causing seasonal influenza. To prepare for the emergence of pandemic influenza, we have established a library of virus strains isolated from birds, pigs, and humans in global surveillance studies.
  
  
  METHODS
  Inactivated whole virus particle (WV) and ether-split (ES) vaccines were prepared from an influenza virus strain, A/swine/Hokkaido/2/1981 (H1N1), from the library and from A/Narita/1/2009 (H1N1) pandemic strain. Each of the vaccines was injected subcutaneously into mice and their potencies were evaluated by challenge with A/Narita/1/2009 (H1N1) virus strain in mice.
  
  
  RESULTS
  A/swine/Hokkaido/2/81 (H1N1), which was isolated from the lung of a diseased piglet, was selected on the basis of their antigenicity and growth capacity in embryonated chicken eggs. Two injections of the WV vaccine induced an immune response in mice, decreasing the impact of disease caused by the challenge with A/Narita/1/2009 (H1N1), as did the vaccine prepared from the homologous strain.
  
  
  CONCLUSIONS
  The WV vaccine prepared from an influenza virus in the library is useful as an emergency vaccine in the early phase of pandemic influenza.
authors: Laboratory of Microbiology, Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Kita 18 Nishi 9, Kita-ku, Sapporo 060-0818, Japan.
authors: Masatoshi
authors: M
authors: Okamatsu
authors: Yoshihiro
authors: Y
authors: Sakoda
authors: Takahiro
authors: T
authors: Hiono
authors: Naoki
authors: N
authors: Yamamoto
authors: Hiroshi
authors: H
authors: Kida
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004638:Emergency Treatment / Q000379:methods; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology* / Q000302:isolation & purification; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000276:immunology*; D007279:Injections, Subcutaneous; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000473:pathology / Q000517:prevention & control*; D013552:Swine
chemical_list: D007252:Influenza Vaccines
references: Vaccine. 2009 Dec 9;27(52):7402-8
references: 19747993
references: J Virol. 2009 Feb;83(4):1572-8
references: 19052090
references: J Virol. 1995 Aug;69(8):4888-97
references: 7609057
references: Scand J Immunol. 2005 Jul;62(1):36-44
references: 16092921
references: Vaccine. 2003 May 1;21(16):1776-9
references: 12686093
references: Virology. 1982 Oct 15;122(1):38-47
references: 6182687
references: Vaccine. 2008 Apr 16;26(17):2127-34
references: 18346824
references: Dev Biol (Basel). 2006;124:69-72
references: 16447496
references: Virus Genes. 2008 Oct;37(2):144-52
references: 18612806
references: Nature. 2009 Jun 25;459(7250):1122-5
references: 19516283
references: J Gen Virol. 1991 Aug;72 ( Pt 8):2007-10
references: 1875195
references: Vaccine. 2008 Dec 2;26(51):6555-63
references: 18848856
references: Virus Res. 2010 Jan;147(1):145-8
references: 19879908
references: N Engl J Med. 2009 Jun 18;360(25):2605-15
references: 19423869
references: Vaccine. 2008 Jan 24;26(4):562-72
references: 18164788
references: J Gen Virol. 1994 Sep;75 ( Pt 9):2183-8
references: 8077918
references: N Engl J Med. 2009 Nov 12;361(20):1945-52
references: 19745214
references: Vaccine. 2010 Jan 8;28(3):780-9
references: 19857455
references: J Virol. 1999 Oct;73(10):8303-7
references: 10482580
references: J Immunol. 1962 Mar;88:320-9
references: 13910995
references: Sci Transl Med. 2010 Mar 31;2(25):25ra24
references: 20424013
references: Arch Virol. 2008;153(11):2041-8
references: 18932020
references: Zentralbl Bakteriol Orig A. 1979 Jul;244(2-3):135-43
references: 506542
references: Science. 2009 Jul 10;325(5937):197-201
references: 19465683
references: Virology. 1988 Jan;162(1):160-6
references: 3336940
references: Virology. 1987 Jul;159(1):109-19
references: 2440178
references: Vaccine. 2006 Nov 10;24(44-46):6691-3
references: 16814431
references: Arch Virol. 2000;145(5):885-93
references: 10881676
references: Microbiol Rev. 1992 Mar;56(1):152-79
references: 1579108
references: Arch Virol. 2008;153(9):1685-92
references: 18651092
references: N Engl J Med. 2009 Dec 17;361(25):2405-13
references: 19745216